SCL Science Inc.

₩2,010As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:246960Healthcare
Country South Korea
PE (Fwd) •••
TSR 8Y CAGR (8.52%)
Div yield —
ROE (14.54%)
Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Beta (5Y) 0.56
PE TTM —
TSR TTM (19.11%)
Mkt cap ₩68.37B
ROIC (1.08%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,186
8.75%
85.49%
Buy 12|0|9|7|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
21.98
22.64
23.60
24.93
18.14%
22.86%
19.97%
20.87%
Revenue₩B
6.987
7.151
7.326
7.758
(3.40%)
1.50%
5.31%
12.26%
Peers (US$50.41M)
Cap (US$)
PE
62.50M
12.82x
56.94M
7.687x
50.08M
9.628x
Capital
TTM
5Y
10Y
Leveragex
0.625
0.083
0.082
EBIT/Intx
1.859
0.377
0.369
Own earn%
(127.96)
26.03
24.33
Sh yield%
6.63
45.69
45.61
Owners
Insiders/Inst%
4.20
72.24
Short interest%
4.68
SBC / revenue%
2.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
2–10
$1 testx
—
Incr. ROIC%
3